High loading dose AmBisome is efficacious and well tolerated in the management of invasive fungal infection in hematology patients.

Despite improved supportive care, and the introduction of less toxic lipid-formulations of amphotericin B deoxycholate and other new antifungal agents the mortality from invasive fungal infection (IFI) in hematology patients remains high. New management strategies are therefore required to improve outcome.